Blog
RSS FeedPosted by Michael Wonder on 18 Jun 2025
Cancer inhibitors scrapped from basic insurance for some users
18 June 2025 - National health care institute Zorginstituut Nederland has scrapped several cancer inhibiting drugs from the basic health ...
Posted by Michael Wonder on 07 Jun 2025
BioCryst achieves reimbursement for Orladeyo across all major European countries
6 June 2025 - Orladeyo (berotralstat) now reimbursed in the Netherlands. ...
Posted by Michael Wonder on 27 Feb 2025
Health insurers worried about court order to cover expensive cancer medicines
26 February 2025 - Health insurance companies are “very concerned” about their ability to force lower prices being restricted after a ...
Posted by Michael Wonder on 05 Jul 2024
Dutch Minister plans to implement new reimbursement system for high cost medicine
27 June 2024 - Concerns have been raised about the relative effectiveness of an increasing number of new medicines at ...